Status:
WITHDRAWN
TIPS or Anticoagulation in Portal Vein Thrombosis
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Thrombosis Portal Vein
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
The PROGRESS is an investigator-initiated, multicentre, randomized, trial comparing anticoagulation, which is the currently most frequently used treatment, alone, versus transjugular intrahepatic port...
Eligibility Criteria
Inclusion
- Recent complete thrombosis of the extrahepatic portal vein either with or without the involvement of intrahepatic branches and with or without involvement of splenic vein and superior mesenteric vein
- Written informed consent
Exclusion
- Malignant Portal Vein thrombosis (neoplastic invasion)
- Intraabdominal malignancy
- Chronic diseases limiting life expectancy in the short term (6 months)
- Liver transplantation
- Unwillingness to participate
- Contraindications to TIPS (including past or present hepatic encephalopathy Grade ≥2)
- Child-Pugh-Turcotte score 11 or more points in patients with advanced chronic liver disease-
Key Trial Info
Start Date :
August 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03422419
Start Date
August 1 2018
End Date
July 31 2021
Last Update
November 1 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.